Performance - Biotech vs. Nasdaq 100
U.S. biotech stocks are still experiencing significant underperformance compared to the Nasdaq 100.
Image: BofA Global Investment Strategy
U.S. biotech stocks are still experiencing significant underperformance compared to the Nasdaq 100.
Image: BofA Global Investment Strategy